Tyra Biosciences, Inc.
TYRA
$10.04
-$0.05-0.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.47% | -28.41% | -2.80% | 20.32% | -7.93% |
| Total Depreciation and Amortization | 13.39% | 0.79% | 3.28% | 19.61% | 22.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -7.52% | 134.59% | -11.85% | -1.80% | -32.85% |
| Change in Net Operating Assets | 1,282.61% | -99.60% | 184.37% | -209.38% | 1,481.24% |
| Cash from Operations | -9.45% | -74.48% | 53.43% | -62.78% | 21.07% |
| Capital Expenditure | 88.46% | 88.94% | -245.59% | 77.45% | -626.51% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -67.77% | 114.95% | -893.68% | 112.66% | -- |
| Cash from Investing | -67.72% | 114.87% | -902.25% | 112.51% | -173,921.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -4.98% | 19.07% | -99.69% | 61,777.78% | -30.62% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -48.52% | -- | -- |
| Cash from Financing | -4.98% | 99.20% | -99.81% | 61,725.62% | -30.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -370.92% | 102.84% | -178.87% | 224.56% | -840.55% |